PharmiWeb.com - Global Pharma News & Resources
10-Oct-2022

Global Incontinence Devices Pipeline Research Report 2022: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Incontinence Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.


The report provides comprehensive information about the Incontinence Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Incontinence devices are externally, or internally worn devices intended to protect the skin from the involuntary loss of urine. The devices tracked under this category are protective garments for incontinence, urinary catheters, and urine bags.

Scope

  • Extensive coverage of the Incontinence Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Incontinence Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Incontinence Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Incontinence Devices Overview

3 Products under Development

3.1 Pipeline Products by Stage of Development

3.2 Pipeline Products by Segment

3.3 Pipeline Products by Territory

3.4 Pipeline Products by Regulatory Path

3.5 Pipeline Products by Estimated Approval Date

3.6 Ongoing Clinical Trials

4 Incontinence Devices - Pipeline Products under Development by Companies

4.1 Incontinence Devices Companies - Pipeline Products by Stage of Development

4.2 Incontinence Devices - Pipeline Products by Stage of Development

5 Incontinence Devices Companies and Product Overview

5.1 3D Urologic LLC

5.2 Affluent Medical SA

5.3 All India Institute of Medical Sciences

5.4 Amber Therapeutics Ltd

5.5 APRUS Bio-Medical Innovations Pvt Ltd

5.6 Aran Biomedical

5.7 AugmentRx Medical Inc.

5.8 Aurie

5.9 Becton Dickinson and Co

5.10 Binding Sciences Ltd

5.11 Biocrede Inc

5.12 BioModics ApS

5.13 Bioring SA (Inactive)

5.14 Boston Children's Hospital

5.15 Boston Scientific Corp

5.16 Brighton Development LLC

5.17 Camstent Ltd

5.18 CathBuddy Inc

5.19 CELLF-Bio LLC

5.20 Ceragenix Pharmaceuticals, Inc. (Inactive)

5.21 Chain Antimicrobials Ltd

5.22 Collamedix Inc

5.23 Coloplast A/S

5.24 Continale Medical Pte Ltd

5.25 Continara Limited (Inactive)

5.26 Continental Dry-Works

5.27 Control Flo Medical LLC

5.28 ConvaTec Group Plc

5.29 Dongbang Medical Co Ltd

5.30 DUALIS MedTech GmbH

5.31 EchoScope Inc

5.32 Elidah, LLC

5.33 Endo International Plc

5.34 EndoStim Inc

5.35 Enox Biopharma Inc (Inactive)

5.36 Ergoresearch Ltd

5.37 Facet Technologies LLC

5.38 Fannin Partners LLC

5.39 Flat Medical Inc

5.40 FLEXIPROBE LTD.

5.41 Floelle Inc.

5.42 Flume Catheter Co Ltd

5.43 FocusStart LLC

5.44 Fuisz Pharma LLC

5.45 GT Urological LLC

5.46 Gweepi Medical Inc.

5.47 Gynamics Ltd

5.48 Implantica CE & Production Ltd

5.49 inContAlert

5.50 Ingenion Medical Ltd

5.51 InterVaal Pte Ltd

5.52 Invent Medic Sweden AB

5.53 Jabil Inc

5.54 Laborie Medical Technologies Inc

5.55 Leading Age Supplies LLC

5.56 Lilium Otsuka Co., Ltd.

5.57 MagCath ApS

5.58 Medici Medical Srl

5.59 Medi-Globe GmbH

5.60 Montana State University

5.61 MyoPowers Medical Technologies France SAS

5.62 N8 Medical LLC

5.63 Novuqare BV

5.64 Olympus Endo Technology America Inc

5.65 OTU Medical Inc

5.66 Pennsylvania State University

5.67 PetVivo Holdings Inc

5.68 PolyNovo Biomaterials Pty Ltd

5.69 Polytechnic University of Catalonia

5.70 Polytechnique Montreal

5.71 Precision Medical Devices Inc

5.72 Prosurg Inc

5.73 Provenmed

5.74 Pyriscence LLC

5.75 Quick-Med Technologies Inc

5.76 RegenMedTX LLC

5.77 Renovia Inc

5.78 Resultados y Calidad del Sistema Sanitario Publico de Andalucia

5.79 Riocath Global AS

5.80 Salusion B.V.

5.81 Sharklet Technologies Inc

5.82 SmartWeave Inc

5.83 Smartz AG

5.84 Solace Therapeutics Inc

5.85 Stanford University

5.86 The Feinstein Institute for Medical Research

5.87 The University of Nottingham

5.88 Tractivus SL

5.89 University of Amsterdam

5.90 University of California San Diego

5.91 University of Michigan Pediatric Device Consortium

5.92 University of North Carolina

5.93 University of Saskatchewan

5.94 University of South Florida

5.95 University of Texas Health Science Center at San Antonio

5.96 University of Utah

5.97 Urinary BioSolutions LLC (Inactive)

5.98 UroDev Medical

5.99 Uromedica Inc

5.100 UroMems SAS

5.101 Urova Medical Inc.

5.102 Vesiflo, Inc.

5.103 Vysera Biomedical Ltd

5.104 Washington University in St Louis

5.105 Watkins Conti Products Inc

5.106 Xennovate Medical LLC

6 Incontinence Devices - Recent Developments

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/ulbrsj


Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 10-Oct-2022